BioStem Technologies BSEM
NASDAQ BSEM
$1.47 +0.43 (+41.35%)
At close: Nov 11, 2026 · 4:00 PM EST

BioStem Technologies (BSEM) Return on Equity [ROE] (2026)

Analysis

BioStem Technologies (BSEM) Return on Equity [ROE] (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Thermo Fisher Scientific 266.22 Bn 242.86 Bn 5.13 Bn 13.20%
2 Abbott Laboratories 191.31 Bn 165.77 Bn 7.39 Bn 9.09%
3 Danaher 166.16 Bn 145.82 Bn 3.84 Bn 8.15%
4 Intuitive Surgical 155.98 Bn 136.40 Bn 2.08 Bn 17.28%
5 Medtronic 130.05 Bn 96.18 Bn 6.34 Bn 17.46%
6 Stryker 123.40 Bn 109.59 Bn 4.25 Bn -4.01%
7 Boston Scientific 64.81 Bn 60.48 Bn 3.43 Bn 13.69%
8 Edwards Lifesciences 59.87 Bn 43.18 Bn 1.35 Bn 9.36%
9 Medline 53.84 Bn 50.96 Bn 1.93 Bn 4.56%
10 BioStem Technologies 18.55 Mn -54.49 Mn 4.84 Mn -37.41%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -37.41%
API Access

BioStem Technologies Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=BSEM&period=max&api_key=YOUR_API_KEY